Although several scoring systems based on clinical parameters, such as HAS-BLED or
HEMORR2HAGES, have been created to assess the 1-year risk for major bleeding in patients
on chronic anticoagulation, they seem inadequate in predicting higher diagnostic yields
of small bowel capsule endoscopy (SBCE) or higher rebleeding rates in patients with
obscure gastrointestinal bleeding (OGIB). The aim of this study was to evaluate the
ability of the new ORBIT score in predicting higher diagnostic yield of SBCE or higher
rebleeding rates in chronically anticoagulated patients with OGIB.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Gastrointestinal EndoscopyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2017 Published by Elsevier Inc.
